ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.768,96
0,33%
S&P 500
5.308,13
0,09%
Dow Jones
39.806,77
-0,49%
Euro vs US Dollar
1,08585
-0,02%
Bitcoin
70.907,14
-0,76%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Applied DNA Sciences Inc (APDN)

  7. Applied DNA Sciences Inc (APDN) News

APDN

Applied DNA Sciences (APDN)

Applied DNA Sciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:APDN
DatumZeitQuelleÜberschriftSymbolFirma
16/05/202423h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
15/05/202403h50Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:APDNApplied DNA Sciences Inc
04/03/202423h18Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:APDNApplied DNA Sciences Inc
12/02/202422h25Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:APDNApplied DNA Sciences Inc
12/02/202422h09Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:APDNApplied DNA Sciences Inc
08/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
08/02/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APDNApplied DNA Sciences Inc
01/02/202422h05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:APDNApplied DNA Sciences Inc
26/01/202422h24Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:APDNApplied DNA Sciences Inc
10/01/202423h16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APDNApplied DNA Sciences Inc
08/01/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
05/01/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
07/12/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
07/12/202322h01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:APDNApplied DNA Sciences Inc
06/12/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
07/11/202323h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
07/11/202323h02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:APDNApplied DNA Sciences Inc
20/09/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
10/08/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
10/08/202322h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APDNApplied DNA Sciences Inc
01/08/202322h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
13/07/202323h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APDNApplied DNA Sciences Inc
07/06/202312h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APDNApplied DNA Sciences Inc
11/05/202322h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APDNApplied DNA Sciences Inc
05/05/202322h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APDNApplied DNA Sciences Inc
03/05/202321h00Business WireApplied DNA to Report Second Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, May 11, 2023NASDAQ:APDNApplied DNA Sciences Inc
07/04/202318h00Business WireApplied DNA's CertainT® Supply Chain Traceability Platform Featured in New York Times Article About the Need for Transparency and Compliance in Global Supply Chains Under Recently Passed U.S. Federal RegulationNASDAQ:APDNApplied DNA Sciences Inc
29/03/202315h00Business WireApplied DNA Achieves Milestone for Large-Scale linearDNA™ Production, Delivers Largest Single Shipment by Volume to DateNASDAQ:APDNApplied DNA Sciences Inc
28/03/202312h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APDNApplied DNA Sciences Inc
22/03/202314h35Business WireApplied DNA Submits Validation Package to New York State Department of Health for Approval of Pharmacogenomic (PGx) AssayNASDAQ:APDNApplied DNA Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:APDN

Kürzlich von Ihnen besucht

TG
TUI1
Tui
DBI
SDXP
SDAX
NYSE
XOM
Exxon Mobil
FX
EURUSD
Euro vs US Dollar
NASDAQ
NVDA
NVIDIA
CCOM
SILVER
SILVER
DBI
MDAX
MDAX
CCOM
US100
US Tech 100
TG
BAS
BASF
TG
DBK
Deutsche Bank
NYSE
JPM
JP Morgan Chase
NYSE
MCD
McDonalds
COIN
SOLUSD
Solana
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten